Holen Sie sich die Stockscreener-App
4.95
2.08%
-0.1051
Handel nachbörslich:
5.02
0.07
+1.41%
Schlusskurs vom Vortag:
$5.0551
Offen:
$5.260358
24-Stunden-Volumen:
4,160
Relative Volume:
0.23
Marktkapitalisierung:
$35.44M
Einnahmen:
$85,000
Nettoeinkommen (Verlust:
$-22.16M
KGV:
-0.1314
EPS:
-37.672
Netto-Cashflow:
$-6.29M
1W Leistung:
+4.43%
1M Leistung:
-16.67%
6M Leistung:
-36.13%
1J Leistung:
-71.34%
1-Tages-Spanne:
$4.95
$5.295
1-Wochen-Bereich:
$4.89
$5.38
52-Wochen-Spanne:
$3.85
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
4.95 | 37.23M | 85,000 | -22.16M | -6.29M | -37.67 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
PAVmed Inc (PAVM) Cash Flow - TradingKey
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc (PAVM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PAVmed Inc (PAVM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PAVmed Inc (PAVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PAVmed Inc (PAVM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc (PAVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PAVmed Inc (PAVM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
PAVM|PAVmed Inc|Price:4.740|Chg%:+0.130 - TradingKey
PAVmed Inc (PAVM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PAVmed Inc (PAVM) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
PAVmed Q1 2026 Earnings: Hefty EPS Miss Masks Optimism as Stock ClimbsLow Growth Earnings - dars.gov.et
Price to sales forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
Price to book forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
Price to earnings forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
Price to earnings forward of PAVmed, Inc. – FWB:1P5 - TradingView
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - GuruFocus
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
PAVmed, Inc. Financial Disclosures & Filings - TradingView
Enterprise value to revenue forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
Enterprise value to EBIT forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
PAVmed Inc.(NasdaqCM: PAVM) added to Russell Microcap Value Benchmark Index - marketscreener.com
PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Index - marketscreener.com
PAVmed Inc.(NasdaqCM: PAVM) added to Russell Microcap Index - marketscreener.com
PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Value Benchmark - marketscreener.com
PAVmed, Inc. Actuals & Estimates (NASDAQ:PAVM) - TradingView
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVM Forecast — Price Target — Prediction for 2027 - TradingView
PAVmed Inc. Files Form 8-K on Amended Employee Stock Purchase Plan (ESPP) – Key SEC Filing Details - Minichart
PAVmed Shareholders Approve Plan Changes at Annual Meeting - TipRanks
PAVmed (PAVM) holders re-elect directors, expand ESPP shares and ratify CBIZ - Stock Titan
PAVmed Inc (PAVMZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PAVmed Inc (PAVMZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAVmed Inc (PAVMZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PAVmed Inc (PAVMZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PAVmed Inc (PAVMZ) Institutional Confidence - TradingKey
PAVmed Inc (PAVMZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
PAVmed Inc (PAVM) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAVmed Inc (PAVM) Institutional Confidence - TradingKey
PAVmed Inc (PAVMZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PAVmed Inc (PAVMZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PAVmed Inc (PAVMZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc. (PAVM) Edges Higher as Bullish Momentum Builds Above Key SupportEarnings Beat Stocks - newsline.com
PAVM Maintains Buy Rating -- Price Target Lowered to $56.00 by A - GuruFocus
PAVmed Inc (PAVM) Stock Price & 30 Year Financial Data - GuruFocus
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target - Yahoo Finance
PAVM assigns Joseph Virgilio to lead medical device portfolio relaunch - MSN
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):